Magnesium Health CEO Zhang Xiaodong releases internal memo: Fully implement AI Inside new strategy, focus on empowering two major business directions.

Zhang Xiaodong, founder and CEO of Mai Xin Health, announced to all employees in an internal letter that the company is launching the AI Inside new strategy. According to the strategic deployment, by 2026, Mai Xin Health will focus on empowering two major business directions with AI Inside as the core: first, in the pharmaceutical field, leveraging real-world payment data to provide pharmaceutical companies with drug accessibility analysis and market strategy support, helping innovative drugs reach and serve more patients; second, in the insurance and medical payment field, continuously upgrading the AI-driven "direct payment" platform capability, through intelligent identification and matching of different insurance responsibilities and payment rules, solving user efficiency and experience in policy understanding, real-time settlement, and claims services.